nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—MUC2—embryo—polycystic ovary syndrome	0.029	0.112	CbGeAlD
Pranlukast—IL5—endocrine gland—polycystic ovary syndrome	0.0193	0.0745	CbGeAlD
Pranlukast—MUC2—female gonad—polycystic ovary syndrome	0.016	0.0616	CbGeAlD
Pranlukast—TNF—vagina—polycystic ovary syndrome	0.0159	0.0612	CbGeAlD
Pranlukast—MUC2—endocrine gland—polycystic ovary syndrome	0.0149	0.0573	CbGeAlD
Pranlukast—CYP2C9—urine—polycystic ovary syndrome	0.0134	0.0515	CbGeAlD
Pranlukast—NFKB1—endometrium—polycystic ovary syndrome	0.0121	0.0466	CbGeAlD
Pranlukast—NFKB1—uterus—polycystic ovary syndrome	0.0111	0.0429	CbGeAlD
Pranlukast—CYSLTR1—uterus—polycystic ovary syndrome	0.011	0.0422	CbGeAlD
Pranlukast—NFKB1—pituitary gland—polycystic ovary syndrome	0.0109	0.0421	CbGeAlD
Pranlukast—NFKB1—adipose tissue—polycystic ovary syndrome	0.0109	0.042	CbGeAlD
Pranlukast—CYSLTR1—adipose tissue—polycystic ovary syndrome	0.0107	0.0412	CbGeAlD
Pranlukast—CYP3A4—urine—polycystic ovary syndrome	0.0102	0.0393	CbGeAlD
Pranlukast—NFKB1—adrenal gland—polycystic ovary syndrome	0.00978	0.0376	CbGeAlD
Pranlukast—CYSLTR1—adrenal gland—polycystic ovary syndrome	0.00961	0.037	CbGeAlD
Pranlukast—NFKB1—female gonad—polycystic ovary syndrome	0.00912	0.0351	CbGeAlD
Pranlukast—NFKB1—vagina—polycystic ovary syndrome	0.00906	0.0349	CbGeAlD
Pranlukast—CYSLTR1—vagina—polycystic ovary syndrome	0.0089	0.0343	CbGeAlD
Pranlukast—NFKB1—endocrine gland—polycystic ovary syndrome	0.00848	0.0326	CbGeAlD
Pranlukast—CYSLTR1—endocrine gland—polycystic ovary syndrome	0.00833	0.0321	CbGeAlD
Pranlukast—ABCC2—adrenal gland—polycystic ovary syndrome	0.00384	0.0148	CbGeAlD
Pranlukast—ABCC2—endocrine gland—polycystic ovary syndrome	0.00333	0.0128	CbGeAlD
Pranlukast—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00222	0.00854	CbGeAlD
Pranlukast—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00169	0.00651	CbGeAlD
Pranlukast—NFKB1—Immune System—FGF18—polycystic ovary syndrome	0.000171	0.000232	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000171	0.000231	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00017	0.00023	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.00017	0.00023	CbGpPWpGaD
Pranlukast—IL5—Immune System—IRS1—polycystic ovary syndrome	0.00017	0.00023	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00017	0.000229	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000169	0.000229	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—IL6—polycystic ovary syndrome	0.000164	0.000222	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000162	0.000219	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000162	0.000219	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00016	0.000216	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000159	0.000215	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NRG1—polycystic ovary syndrome	0.000159	0.000214	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000158	0.000214	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000158	0.000214	CbGpPWpGaD
Pranlukast—IL5—Immune System—AKT2—polycystic ovary syndrome	0.000157	0.000213	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000157	0.000212	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—GAB1—polycystic ovary syndrome	0.000156	0.000211	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000156	0.000211	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000156	0.000211	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000156	0.000211	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000156	0.00021	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—polycystic ovary syndrome	0.000155	0.000209	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000154	0.000208	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—IL6—polycystic ovary syndrome	0.000153	0.000207	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NRG1—polycystic ovary syndrome	0.000152	0.000206	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL6—polycystic ovary syndrome	0.000151	0.000204	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000151	0.000204	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000151	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—LEP—polycystic ovary syndrome	0.000151	0.000203	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00015	0.000202	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000147	0.000199	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000147	0.000199	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000147	0.000199	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000145	0.000196	CbGpPWpGaD
Pranlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000144	0.000194	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000143	0.000193	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CAMK2D—polycystic ovary syndrome	0.000142	0.000192	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—polycystic ovary syndrome	0.000142	0.000192	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000142	0.000191	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000141	0.000191	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00014	0.00019	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00014	0.000189	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TNRC6B—polycystic ovary syndrome	0.00014	0.000189	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000139	0.000188	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000138	0.000187	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000138	0.000187	CbGpPWpGaD
Pranlukast—IL5—Immune System—BCL2—polycystic ovary syndrome	0.000138	0.000186	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000137	0.000185	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000136	0.000184	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000136	0.000184	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000136	0.000184	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CRP—polycystic ovary syndrome	0.000136	0.000184	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IRS2—polycystic ovary syndrome	0.000136	0.000184	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000135	0.000182	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—VEGFA—polycystic ovary syndrome	0.000134	0.000181	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000133	0.000179	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000132	0.000179	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—PPARG—polycystic ovary syndrome	0.000131	0.000177	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—IRS2—polycystic ovary syndrome	0.000131	0.000176	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00013	0.000176	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00013	0.000176	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000129	0.000175	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FST—polycystic ovary syndrome	0.000129	0.000175	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—INS—polycystic ovary syndrome	0.000129	0.000174	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000129	0.000174	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000128	0.000173	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000128	0.000173	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—polycystic ovary syndrome	0.000128	0.000173	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000128	0.000172	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000126	0.00017	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000126	0.00017	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000126	0.00017	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—polycystic ovary syndrome	0.000125	0.000168	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—AKT2—polycystic ovary syndrome	0.000124	0.000168	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000124	0.000168	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000124	0.000167	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LEP—polycystic ovary syndrome	0.000123	0.000167	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000123	0.000167	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ATF1—polycystic ovary syndrome	0.000123	0.000166	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—polycystic ovary syndrome	0.000123	0.000166	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000122	0.000164	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000119	0.000161	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IRS1—polycystic ovary syndrome	0.000119	0.00016	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000118	0.00016	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—polycystic ovary syndrome	0.000118	0.00016	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000117	0.000157	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000116	0.000157	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000116	0.000157	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—LEP—polycystic ovary syndrome	0.000115	0.000155	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—IRS1—polycystic ovary syndrome	0.000114	0.000154	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TAB1—polycystic ovary syndrome	0.000113	0.000153	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000113	0.000152	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000113	0.000152	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PRL—polycystic ovary syndrome	0.000112	0.000152	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000111	0.00015	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000111	0.00015	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00011	0.000149	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00011	0.000148	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—AKT2—polycystic ovary syndrome	0.00011	0.000148	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000108	0.000146	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000108	0.000145	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—POMC—polycystic ovary syndrome	0.000106	0.000143	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000106	0.000143	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000106	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—AKT2—polycystic ovary syndrome	0.000105	0.000142	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—INS—polycystic ovary syndrome	0.000105	0.000142	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000103	0.00014	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000103	0.000139	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000103	0.000139	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000102	0.000138	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000102	0.000138	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000102	0.000137	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000101	0.000137	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000101	0.000137	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000101	0.000137	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.0001	0.000135	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PPARG—polycystic ovary syndrome	9.99e-05	0.000135	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—INS—polycystic ovary syndrome	9.8e-05	0.000132	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.67e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—INSR—polycystic ovary syndrome	9.67e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—BCL2—polycystic ovary syndrome	9.59e-05	0.00013	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—AKT2—polycystic ovary syndrome	9.48e-05	0.000128	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL18—polycystic ovary syndrome	9.45e-05	0.000128	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	9.42e-05	0.000127	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	9.39e-05	0.000127	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—polycystic ovary syndrome	9.28e-05	0.000125	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NRG1—polycystic ovary syndrome	9.24e-05	0.000125	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	9.21e-05	0.000124	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	9.19e-05	0.000124	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	9.05e-05	0.000122	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IRS2—polycystic ovary syndrome	9.04e-05	0.000122	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PGR—polycystic ovary syndrome	8.96e-05	0.000121	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—polycystic ovary syndrome	8.85e-05	0.00012	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LEP—polycystic ovary syndrome	8.85e-05	0.00012	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—polycystic ovary syndrome	8.71e-05	0.000118	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	8.59e-05	0.000116	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PLAT—polycystic ovary syndrome	8.33e-05	0.000112	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GHRL—polycystic ovary syndrome	8.33e-05	0.000112	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	8.31e-05	0.000112	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	8.19e-05	0.000111	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	8.15e-05	0.00011	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—polycystic ovary syndrome	8.13e-05	0.00011	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	8.01e-05	0.000108	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	8.01e-05	0.000108	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ATF1—polycystic ovary syndrome	7.94e-05	0.000107	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IRS2—polycystic ovary syndrome	7.92e-05	0.000107	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CRP—polycystic ovary syndrome	7.92e-05	0.000107	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IRS1—polycystic ovary syndrome	7.89e-05	0.000107	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—polycystic ovary syndrome	7.79e-05	0.000105	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.75e-05	0.000105	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	7.7e-05	0.000104	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—POMC—polycystic ovary syndrome	7.6e-05	0.000103	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	7.58e-05	0.000102	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—INS—polycystic ovary syndrome	7.56e-05	0.000102	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NGFR—polycystic ovary syndrome	7.33e-05	9.9e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF1—polycystic ovary syndrome	7.31e-05	9.88e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	7.31e-05	9.87e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKT2—polycystic ovary syndrome	7.3e-05	9.87e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PRL—polycystic ovary syndrome	7.26e-05	9.81e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—polycystic ovary syndrome	7.12e-05	9.61e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.94e-05	9.38e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IRS1—polycystic ovary syndrome	6.91e-05	9.34e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.89e-05	9.31e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	6.71e-05	9.07e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	6.68e-05	9.03e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	6.68e-05	9.03e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.65e-05	8.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AKT2—polycystic ovary syndrome	6.4e-05	8.64e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GNAS—polycystic ovary syndrome	6.39e-05	8.63e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	6.36e-05	8.6e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	6.21e-05	8.39e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—polycystic ovary syndrome	6.19e-05	8.37e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	6.19e-05	8.37e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.09e-05	8.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	6.07e-05	8.2e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	6e-05	8.11e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NRG1—polycystic ovary syndrome	5.98e-05	8.07e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—polycystic ovary syndrome	5.62e-05	7.6e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.59e-05	7.55e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BCL2—polycystic ovary syndrome	5.59e-05	7.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	5.41e-05	7.31e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	5.28e-05	7.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	5.28e-05	7.14e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	5.16e-05	6.97e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IRS2—polycystic ovary syndrome	5.12e-05	6.92e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.1e-05	6.89e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LEP—polycystic ovary syndrome	5.01e-05	6.77e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—polycystic ovary syndrome	4.97e-05	6.71e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.84e-05	6.53e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.77e-05	6.45e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	4.71e-05	6.36e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—polycystic ovary syndrome	4.6e-05	6.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	4.6e-05	6.21e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.47e-05	6.04e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	4.45e-05	6.02e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	4.43e-05	5.98e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—POMC—polycystic ovary syndrome	4.3e-05	5.81e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—polycystic ovary syndrome	4.28e-05	5.79e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—INS—polycystic ovary syndrome	4.28e-05	5.78e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	4.2e-05	5.67e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.14e-05	5.59e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.14e-05	5.59e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	4.1e-05	5.54e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	4e-05	5.41e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	3.97e-05	5.36e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.93e-05	5.31e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	3.83e-05	5.17e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	3.68e-05	4.97e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.66e-05	4.94e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	3.63e-05	4.91e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.61e-05	4.87e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	3.57e-05	4.82e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	3.43e-05	4.63e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	3.4e-05	4.6e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	3.38e-05	4.56e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—polycystic ovary syndrome	3.3e-05	4.46e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.1e-05	4.19e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.03e-05	4.1e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	2.94e-05	3.97e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TH—polycystic ovary syndrome	2.92e-05	3.95e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—polycystic ovary syndrome	2.89e-05	3.91e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	2.84e-05	3.84e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.7e-05	3.65e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.7e-05	3.65e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	2.67e-05	3.61e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.62e-05	3.54e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.52e-05	3.41e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.43e-05	3.28e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.4e-05	3.24e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.38e-05	3.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.27e-05	3.07e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.26e-05	3.06e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.23e-05	3.01e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.15e-05	2.91e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.01e-05	2.71e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.93e-05	2.6e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.87e-05	2.53e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—polycystic ovary syndrome	1.87e-05	2.53e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.76e-05	2.38e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.63e-05	2.2e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.61e-05	2.17e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.6e-05	2.16e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.57e-05	2.12e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.5e-05	2.02e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.42e-05	1.92e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.32e-05	1.79e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.07e-05	1.45e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.06e-05	1.43e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.05e-05	1.42e-05	CbGpPWpGaD
